Please use this identifier to cite or link to this item:
|Title:||Patient knowledge of colorectal cancer therapy side effects|
Azzopardi, Lilian M.
|Keywords:||Cancer -- Treatment|
Oncology -- Patients -- Care
Tumors -- Case Reports
|Citation:||Pirotta, I., Serracino-Inglott, A., Azzopardi, L.M., & Anastasi, A. (2011). Patient knowledge of colorectal cancer therapy side effects. Hospital Pharmacy Europe, 58, 24-26.|
|Abstract:||One of the highly specialised areas of practice that has gained substantial interest over the past few decades is oncology pharmacy. According to the Malta National Cancer Registry, colorectal cancer is reported to being the second most common neoplasia following breast and the second most common cancer death following lung cancer in Malta. When comparing the estimated age-standardised rates (European Standard) of colorectal cancer incidence per 100,000, Malta is slightly higher in females (36.2) and slightly lower in males (51.5) than the European average standard of 34.6 and 55.4 for females and males respectively.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|555.25 kB||Adobe PDF||View/Open Request a copy|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.